Overview

Combined Spinal-epidural Anesthesia for Cesarean Section Without Prophylactical Prehydration and Vasopressors

Status:
Recruiting
Trial end date:
2021-11-30
Target enrollment:
0
Participant gender:
Female
Summary
Hypotension is a common complication in pregnant women after spinal anesthesia and related with the dose of local anesthetic. Injecting small dose local anesthetic into subarachnoid space can decrease the incidence of hypotension, but increase the risk of incomplete analgesia and muscle relaxation. The investigators hypothesize there is an optimal dose of bupivacaine and ropivacaine for subarachnoid injection in pregnant women, which can cause enough anesthesia and obviously decrease the incidence of hypotension without prophylactical prehydration and vasopressors. To verify this hypothesis, full-term pregnant women who were scheduled for elective cesarean section were recruited.Combined spinal-epidural anesthesia was performed for pregnant women after written informed consents. The dose of bupivacaine or ropivacaine is small and depends on height of pregnant women. The blood pressure, heart rate, respiratory rate, SpO2 and fetal heart rate were recorded and the blood flow volume of uterine artery was monitored The sensory and motor block were evaluated. After delivery, umbilical blood samples were taken for blood gas analysis. APGAR scores and neurological behavior of infant were evaluated and recorded. In the intraoperative period, side-effects and requirement for sedation, epidural injection or general anesthesia were noted. The quality of anaesthesia (judged by the anaesthetist), the quality of muscle relaxation (judged by the surgeon) and the degree of intraoperative comfort (judged by the patient) were recorded as excellent, good, fair or poor.
Phase:
N/A
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Shenzhen People's Hospital
Treatments:
Anesthetics
Bupivacaine
Ropivacaine
Vasoconstrictor Agents
Criteria
Inclusion Criteria:

- Pregnant women who were scheduled for cesarean section.

Exclusion Criteria:

- Women with cardiovascular disease, fetal abnormalities, placental abruption, placenta
previa, placental abnormalities, sidewall placenta, abnormal fetal heart rate and
spinal anesthesia contraindications.